GeneVentiv Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.5M
- Investors
-
3
GeneVentiv Therapeutics General Information
Description
Developer of preclinical adeno-associated virus gene therapies designed to treat hematologic and metabolic genetic disorders. The company develops viral vector therapies for hemophilia and Pompe disease, including gene delivery and targeted gene editing technologies, enabling researchers and healthcare providers to develop treatments for rare genetic diseases.
Contact Information
Website
www.geneventiv.comCorporate Office
- 150 Fayetteville Street
- Suite 2300
- Raleigh, NC 27601
- United States
Corporate Office
- 150 Fayetteville Street
- Suite 2300
- Raleigh, NC 27601
- United States
GeneVentiv Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 16-Apr-2024 | $2.5M | Completed | Generating Revenue | ||
| 3. Seed Round | 02-Aug-2022 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 08-Feb-2022 | $50K | $50K | Completed | Pre-Clinical Trials | |
| 1. Spin-Off | 01-Jan-2020 | Completed | Generating Revenue |
GeneVentiv Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
GeneVentiv Therapeutics Signals
GeneVentiv Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| KickStart Venture Services | Accelerator/Incubator | Minority | ||
| University of North Carolina at Chapel Hill | University |
GeneVentiv Therapeutics FAQs
-
When was GeneVentiv Therapeutics founded?
GeneVentiv Therapeutics was founded in 2020.
-
Where is GeneVentiv Therapeutics headquartered?
GeneVentiv Therapeutics is headquartered in Raleigh, NC.
-
What is the size of GeneVentiv Therapeutics?
GeneVentiv Therapeutics has 4 total employees.
-
What industry is GeneVentiv Therapeutics in?
GeneVentiv Therapeutics’s primary industry is Biotechnology.
-
Is GeneVentiv Therapeutics a private or public company?
GeneVentiv Therapeutics is a Private company.
-
What is GeneVentiv Therapeutics’s current revenue?
The current revenue for GeneVentiv Therapeutics is .
-
How much funding has GeneVentiv Therapeutics raised over time?
GeneVentiv Therapeutics has raised $1.7M.
-
Who are GeneVentiv Therapeutics’s investors?
National Institutes of Health, KickStart Venture Services, and University of North Carolina at Chapel Hill have invested in GeneVentiv Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process